Addition of platinum derivatives to fluoropyrimidine-based neoadjuvant chemoradiotherapy for stage II/III rectal cancer: systematic review and meta-analysis

AbstractBackground. Current guidelines recommend neoadjuvant therapy for patients with stage II or III rectal cancer. The addition of platinum derivatives to f

Saved in:

Bibliographic Details
Main Authors:	Hüttner, Felix (Author) , Probst, Pascal (Author) , Kalkum, Eva (Author) , Hackbusch, Matthes (Author) , Jensen, Katrin (Author) , Ulrich, Alexis (Author) , Debus, Jürgen (Author) , Jäger, Dirk (Author) , Diener, Markus K. (Author)
Format:	Article (Journal)
Language:	English
Published:	May 11, 2019
In:	Journal of the National Cancer Institute Year: 2019, Volume: 111, Issue: 9, Pages: 887-902
ISSN:	1460-2105
DOI:	10.1093/jnci/djz081
Online Access:	Verlag, Volltext: https://doi.org/10.1093/jnci/djz081 Verlag, Volltext: https://academic.oup.com/jnci/article/111/9/887/5488190
Author Notes:	Felix J. Hüttner, Pascal Probst, Eva Kalkum, Matthes Hackbusch, Katrin Jensen, Alexis Ulrich, Jürgen Debus, Dirk Jäger, Markus K. Diener

Description
Summary:	AbstractBackground. Current guidelines recommend neoadjuvant therapy for patients with stage II or III rectal cancer. The addition of platinum derivatives to f
Item Description:	Gesehen am 28.11.2019
Physical Description:	Online Resource
ISSN:	1460-2105
DOI:	10.1093/jnci/djz081